Skip to content

KORU Medical Systems KRMD Free cash flow margin

Discontinued — last reported Q3 '22

Free cash flow margin at other companies

Baxter International logo
Baxter InternationalBAX
3%-2.4pp
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
16.4%
Embecta Corp. logo
Embecta Corp.EMBC
19.6%+16.0pp
InfuSystem Holdings logo
InfuSystem HoldingsINFU
16.2%+1.0pp
UFP Technologies logo
UFP TechnologiesUFPT
12.3%+2.0pp
ICU Medical logo
ICU MedicalICUI
4.2%-1.2pp

Other financials

Income statement

See full
Revenue$11.8M+22.1%
Gross profit$7.2M+19.6%
Operating income-$864.9K+30.5%
Net income-$807.1K+30.8%
EPS (diluted)-$0.02+33.3%

Balance sheet

See full
Cash & equivalents$8.8M+0.4%
Total debt$3.5M-2.8%
Total equity$16.9M+3.5%
Total assets$28.6M+5.1%

Cash flow

See full
Operating cash flow$14.7K+106%
CapEx$46.2K-89.6%
Free cash flow-$31.5K+95.4%

Valuation

See full
Market cap$206.24M+24.9%
Enterprise value$200.96M+25.1%
P/S4.8×+0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin-6%-2.3pp
Net margin-5.3%-2.1pp

Returns & leverage

See full
Return on equity-13.7%-4.8pp
Debt / equity0.2×0.0×
Current ratio2.3×-0.1×

Where this comes from

Calculated from KORU Medical Systems’s reported figures.

Based on trailing twelve months.

The official record: KORU Medical Systems’s 10-Q, filed November 9, 2022, on SEC EDGAR. View the filing →

Ask your AI about KORU Medical Systems's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KORU Medical Systems's free cash flow margin?
KORU Medical Systems (KRMD) reported free cash flow margin of -37.1% in Q3 2022.
How has KORU Medical Systems's free cash flow margin changed year-over-year?
KORU Medical Systems's free cash flow margin decreased by 39.0% year-over-year, from -26.7% to -37.1%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.